Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...

UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

The popularity of GLP-1 drugs has insurance companies scrambling to satisfy consumer access while reining in exorbitant costs ...

Cigna is basing employer ... expensive new GLP-1 agonist anti-obesity drugs are driving up costs. "We've remained disciplined with our own pricing strategy," Evanko said. "We're pricing for ...

Trump also reiterated his long-standing criticism of companies that own pharmacy benefit managers, like CVS and Cigna, for what he described as their role in distorting drug pricing.

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.